Navigation Links
Breast Cancer Action Sues to End Gene Patenting

Lawsuit Seeks Increased Access to Information for Patients of Breast Cancer

SAN FRANCISCO, May 12 /PRNewswire-USNewswire/ -- Breast Cancer Action (BCA) is challenging the legality of patenting human "breast cancer genes." BCA is joining the American Civil Liberties Union in suing Myriad Genetics (a private biotechnology company based in Utah), that currently holds the patent on the two human genes known as BRAC1 and BRAC2.

The BRAC1 and BRAC2 genes are present in every human. However, people with certain genetic mutations on these genes are at an increased risk of developing breast and ovarian cancer. Myriad holds exclusive rights to these genes and their mutations and to the research performed on them. Testing for the BRAC1 and BRAC2 mutations can only be performed at Myriad labs and currently costs over $3,000.

Since 1998, when BRAC1 & 2 were first patented, BCA has maintained that the patenting of human genes interferes with patients' access to genetic testing and medical care.

"The time has finally arrived for the courts to decide who owns our genes," said Barbara Brenner, executive director of Breast Cancer Action.

When one company controls all the testing, less information and resources are available to both patients and researchers. Women unable to afford the $3,500 fee are prevented from access to the test; women seeking second opinions on any results they might receive have nowhere to go; and women of African, Hispanic, or Asian decent are at a significant disadvantage because they disproportionately receive ambiguous results when tested by Myriad.

"There are so many injustices and inequities in breast cancer," Brenner said. "The time has come to address them in all their forms -- as they affect genetic risk, as well as social, political, and economic realities. This case is an important first step."

BCA joins this litigation in hopes that it will open doors to better research and information, and ultimately better health care for women regardless of their economic situation or their racial background.

The case, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al., is filed in the U.S District Court for the Southern District of New York.

Breast Cancer Action ( -- is a non-profit education and advocacy organization that does not accept funding from pharmaceutical companies or any other organizations that profit from or contribute to the breast cancer epidemic.

SOURCE Breast Cancer Action
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics
2. ACLU Challenges Patents on Breast Cancer Genes
3. Scientists identify gene in breast cancer pathway
5. Video: Reese Witherspoon Joins Avon Foundation for Women and San Francisco General Hospital to Celebrate 5th Anniversary of Avon Comprehensive Breast Center
6. Collaborates With, Providing Quality Awareness Sponsorships to #1 Breast Cancer Resource Online
7. Park Meadows Cosmetic Surgery, a Pioneer in DIEP Flap Breast Reconstruction Surgery in Colorado, Introduces New, Informative Website
8. International Breast Milk Project Helps Mothers Worldwide
9. New technique may help detect potential breast cancer spread
10. Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer
11. Genes Linked to Spread of Breast Cancer
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology: